Assessing the Association between Diabetes, and Depression: A Study among Adults with type 2 Diabetes in Bangladesh
Md. Moniruzzaman Roky
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
Sazin Islam *
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
Md. Mehedi Hasan
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
Md. Jewel Rana
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
Md. Waly Ullah
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
Sharmin Akter
Central Medical College, Cumilla-3500, Bangladesh.
Md. Shariful Islam
Department of Public Health, First Capital University of Bangladesh, Chuadanga-7200, Bangladesh.
*Author to whom correspondence should be addressed.
Abstract
Objective: The objective of the study was to examine the relationship between diabetes, depression, and the risk of developing Depression, particularly Alzheimer's disease. The study aimed to understand the impact of these conditions on cognitive performance and to explore potential pathways linking diabetes to cognitive impairment. The study also aimed to examine the relationship between depression and Depression in the context of diabetes, and to understand the role of comorbidities such as cardiovascular disease, hypertension, and systemic inflammation in this relationship
Materials and Methods: This is a study to survey adult patients (age 18 and above) with type 2 diabetes, who are registered at a primary care clinic in an urban setting in Bangladesh. 200 patients was selected randomly from the sampling frame, who are stratified by age and gender. They will fill a structured questionnaire and self-report questionnaires such as Patient Health Questionnaire-9 (PHQ-9), Diabetes Distress Scale (DDS) and Diabetes Self-Care Activities Measure (DSAM) to assess the presence and severity of depression, distress related to diabetes management and self-care behaviors related to diabetes management respectively. The study has been approved by the Institutional Review Board at the University and venous blood samples was taken for plasma C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fibrinogen.
Results: This study shows that analyzed socio-demographic and health data for a group of 102 individuals, divided into two groups: those with depression and those without depression. The study found that there are statistically significant differences in some variables between the two groups, such as BMI, treatment of DM and HbA1c levels, but not in others like smoking, hypertension, hyperlipidemia and duration of DM.
Conclusion: This research suggests that there is a strong association between diabetes, depression, and the risk of developing Depression. It was found that diabetes increases the risk of Depression, particularly Alzheimer's disease, and that depression also increases the risk of AD by twofold, as well as the risk of other forms of Depression. The relationship between depression and Depression is not well understood, but it is possible that depression may be a symptom of the presence of amyloid and tau signals in AD. It was recommended that both diabetes and depression should be diagnosed and treated early on, in order to mitigate the risk of developing Depression. Additionally, it is suggested that identifying and addressing depression in older adults may be an important strategy for preventing cognitive decline. The link between diabetes, depression, and Depression may be related to underlying factors such as inflammation and altered insulin pathways. Furthermore, the ratio between MPV/PLT ratio may be used as a diagnostic tool for IDA (Iron Deficiency Anemia) in the future.
Keywords: Depression, inflammatory markers, Bangladesh
How to Cite
References
Kirkby R, Al Saif A, el-din Mohamed G. Validation of an Arabic translation of the Zung Self-Rating Depression Scale. Ann Saudi Med. 2005;25(3):205-208.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
Herder C, Hermanns N. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Semin Immunopathol. 2019;41(4):477-489.
Cherbuin N, Kim S, Anstey KJ. Depression risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open. 2015;5(12):e008853.
Arthur A, Savva GM, Barnes LE, Borjian-Boroojeny A, Dening T, Jagger C, Matthews FE, Robinson L, Brayne C. The Cognitive Function and Ageing Studies Collaboration; et al. Changing prevalence and treatment of depression among older people over two decades. Br. J. Psychiatry. 2019;216:49–54.
Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW. Major depressive disorder and hypothalamic pituitary adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry. 2009;66(6):617-626.
Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry. 2007;62(5):472-478.
Rusanen M, Kivipelto M, Quesenberry CP Jr, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular Depression. Arch Intern Med. 2011;171(4):333-339.
Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, Ludman EJ, Young BA, Williams LH, McCulloch DK, Von Korff M. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2):264-269.
Doyle TA, de Groot M, Harris T et al. Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study. J Psychosom Res 2013;75(5): 419-424.
Kirkby R, Al Saif A, el-din Mohamed G. Validation of an Arabic translation of the Zung Self-Rating Depression Scale. Annals of Saudi Medicine. 2005;25(3):205-208.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, others. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005; 53:695-699.
Herder C, Hermanns N. Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes. Seminars in Immunopathology. 2019; 41(4):477-489.
Cherbuin N, Kim S, Anstey KJ. Depression risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open. 2015;5(12):e008853.
Arthur A, Savva GM, Barnes LE, Borjian-Boroojeny A, Dening T, Jagger C, Matthews FE, Robinson L, Brayne C, others. Changing prevalence and treatment of depression among older people over two decades. The British Journal of Psychiatry. 2019;216:49-54.
Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Archives of General Psychiatry. 2009;66(6):617-626.
Peavy GM, Lange K L, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biological Psychiatry. 20076;2(5):472-478.
Rusanen M, Kivipelto M, Quesenberry CP, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular depression. Archives of Internal Medicine. 2011;171(4):333-339.
Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, Ludman EJ, Young BA, Williams LH, McCulloch DK, Von Korff M. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33(2): 264-269.
Doyle TA, de Groot M, Harris T, others. Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study. Journal of Psychosomatic Research. 2013;75(5):419-424.
Herder C, Fürstos JF, Nowotny B, et al. Associations between inflammation-related biomarkers and depressive symptoms in individuals with Recently Diagnosed Type 1 and Type 2 Diabetes; 2017.
Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, Ciebiada M, Loba J. Plasma levels of thrombomodulin, plasminogen activator inhibitor-1, and fibrinogen in elderly, diabetic patients with depressive symptoms. Aging Clinical and Experimental Research. 2016;28(5):843-851.
Ryan CM, Williams TM, Finegold DN, Orchard TJ. Cognitive function in adults with type 1 (insulin dependent) diabetes mellitus of long duration: Effect of recurrent hypoglycemia and other chronic complications. Diabetologia. 1993;36:329-334.
Wredling R, Levander S, Adamson U, Lins PE. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycemia in man. Diabetologia. 1990;33:152-157.
Mooradian AD. Diabetic complication of the central nervous system. Endocrine Reviews. 1988;9:346-356.
Biessels GJ, Kappelle AC. Cerebral function in diabetes mellitus. Diabetologia. 1994;37;643-650.
Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type 2 (non-insulin dependent) diabetes mellitus associated with an increased risk of cognitive dysfunction? Diabetes Care, 1997;20:438-445.
Kilzieh N, Rastam S, Maziak W, Ward KD. Comorbidity of depression with chronic diseases: a population-based study in Aleppo, Syria. International Journal of Psychiatry in Medicine. 2008;38(2):169-184. DOI: 10.2190/PM.38.2.d. PMID: 18724568; PMCID: PMC2556632